Crucell N.V. and DSM Biologics have opened the Percivia PER.C6 Development Center as part of a previously announced joint venture between the two companies. Percivia was designed to advance the PER.C6 cell line and provide solutions for the production of pharmaceutical proteins to licensees utilizing the PER.C6 human cell line in the biopharma industry. “Percivia’s state-of-the-art facility will support the use of PER.C6 cells in the manufacturing of human therapeutic proteins,&...